Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the documentation and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-08T01:49:20.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, a minor backend/UI update that does not modify study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T12:29:19.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.4.1' was added and the previous label 'Revision: v3.4.0' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T07:24:56.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Show glossary toggle added; capitalization standardized for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. Revision updated to v3.4.0 (from v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-24T06:03:20.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-17T04:55:12.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The Locations section now lists many new study sites across the United States, Australia, Canada, Hong Kong, India, Japan, and other regions, broadening the geographic footprint of the trial.
    Difference
    2%
    Check dated 2025-12-19T12:57:24.000Z thumbnail image

Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.